Literature DB >> 19436932

Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures.

S Jurado1, X Nogués, L Agueda, N Garcia-Giralt, R Urreizti, G Yoskovitz, L Pérez-Edo, G Saló, R Carreras, L Mellibovsky, S Balcells, D Grinberg, A Díez-Pérez.   

Abstract

UNLABELLED: Osteoprotegerin plays a key role in bone remodelling. We studied the association between 24 polymorphisms and haplotypes on the OPG gene and bone mineral density and fractures. After multiple-testing correction, one SNP and two block-haplotypes were significantly associated with FN BMD. Two other block-haplotypes were associated with fracture. INTRODUCTION AND HYPOTHESIS: Osteoprotegerin (OPG) plays a key role in bone remodelling. Here we studied the association between polymorphisms and haplotypes on the OPG gene and bone mineral density (BMD) and fractures.
METHODS: Twenty-four single nucleotide polymorphisms (SNPs) were selected to cover six haplotypic blocks and were genotyped in 964 postmenopausal Spanish women. Haplotypes were established with HaploStats. Association was analysed by GLM (for BMD) and logistic regression (for fractures) both at single SNP and haplotype levels.
RESULTS: Upon adjustment for multiple testing (p < 0.0073), one of the SNPs (SNP #17, rs1032129) remained significantly associated with FN BMD (p = 0.001). Four block-haplotypes stood multiple-testing correction. Two remained associated with FN BMD and two with fracture. The association of block-4 haplotype "AC" (of SNPs #18 and #17) with FN BMD (p = 0.0002) was stronger than that of SNP#17 alone and was the best result overall. A global assessment of the results indicated that all the alleles and haplotypes with a protective effect, at p < 0.05, belonged to a frequent long-range haplotype.
CONCLUSIONS: In conclusion, these results provide a detailed picture of the involvement of common variants and haplotypes of the OPG gene in bone phenotypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19436932     DOI: 10.1007/s00198-009-0956-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  39 in total

Review 1.  Using haplotype blocks to map human complex trait loci.

Authors:  Lon R Cardon; Gonçalo R Abecasis
Journal:  Trends Genet       Date:  2003-03       Impact factor: 11.639

2.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.

Authors:  S Purcell; S S Cherny; P C Sham
Journal:  Bioinformatics       Date:  2003-01       Impact factor: 6.937

3.  A haplotype map of the human genome.

Authors: 
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

Review 4.  Minireview: the OPG/RANKL/RANK system.

Authors:  S Khosla
Journal:  Endocrinology       Date:  2001-12       Impact factor: 4.736

5.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

6.  The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women.

Authors:  Hong-yan Zhao; Jian-min Liu; Guang Ning; Yong-ju Zhao; Lian-zhen Zhang; Li-hao Sun; Man-yin Xu; A G Uitterlinden; Jia-lun Chen
Journal:  Osteoporos Int       Date:  2005-03-22       Impact factor: 4.507

7.  Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.

Authors:  Barbara Arko; Janez Prezelj; Andreja Kocijancic; Radovan Komel; Janja Marc
Journal:  Maturitas       Date:  2005-07-16       Impact factor: 4.342

8.  Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men.

Authors:  Yoshiji Yamada; Fujiko Ando; Naoakira Niino; Hiroshi Shimokata
Journal:  Mol Genet Metab       Date:  2003-11       Impact factor: 4.797

9.  Osteoprotegerin gene polymorphisms in men with coronary artery disease.

Authors:  Muhidien Soufi; Michael Schoppet; Alexander M Sattler; Matthias Herzum; Bernhard Maisch; Lorenz C Hofbauer; Juergen R Schaefer
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

10.  Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor.

Authors:  T Morinaga; N Nakagawa; H Yasuda; E Tsuda; K Higashio
Journal:  Eur J Biochem       Date:  1998-06-15
View more
  12 in total

Review 1.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

2.  GREB1 genetic variants are associated with bone mineral density in Caucasians.

Authors:  Kevin G Hegarty; Frances J Drummond; Mary Daly; Fergus Shanahan; Michael G Molloy
Journal:  J Bone Miner Metab       Date:  2017-03-14       Impact factor: 2.626

3.  Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province.

Authors:  Yizhou Li; Yongchang Guo; Quanjian Wang; Yongri Ouyang; Yuju Cao; Tianbo Jin; Jianzhong Wang
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

4.  Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene.

Authors:  Wendy K Steagall; Gustavo Pacheco-Rodriguez; Connie G Glasgow; Yoshihiko Ikeda; Jing-Ping Lin; Gang Zheng; Joel Moss
Journal:  Am J Pathol       Date:  2013-07-16       Impact factor: 4.307

5.  Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).

Authors:  R M R Pereira; C P Figueiredo; C C Cha; V F Caparbo; R M Oliveira; A S Franco; P R Menezes; I de Castro; L F Onuchic
Journal:  Osteoporos Int       Date:  2016-06-16       Impact factor: 4.507

6.  "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".

Authors:  María Piedra; María T García-Unzueta; Ana Berja; Blanca Paule; Bernardo A Lavín; Carmen Valero; José A Riancho; José A Amado
Journal:  BMC Med Genet       Date:  2011-12-20       Impact factor: 2.103

7.  Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men.

Authors:  Delnaz Roshandel; Kate L Holliday; Stephen R Pye; Kate A Ward; Steven Boonen; Dirk Vanderschueren; Herman Borghs; Ilpo T Huhtaniemi; Judith E Adams; Gyorgy Bartfai; Felipe F Casanueva; Joseph D Finn; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E Lean; Neil Pendleton; Margus Punab; Alan J Silman; Frederick C Wu; Wendy Thomson; Terence W ONeill
Journal:  Calcif Tissue Int       Date:  2011-10-02       Impact factor: 4.333

Review 8.  The transforming growth factor-β1 (TGF-β1) gene polymorphisms (TGF-β1 T869C and TGF-β1 T29C) and susceptibility to postmenopausal osteoporosis: a meta-analysis.

Authors:  Jiajia Sun; Chi Zhang; Lei Xu; Mingyuan Yang; Huilin Yang
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

9.  Association analysis between g.18873C>T and g.27522G>A genetic polymorphisms of OPG and bone mineral density in Chinese postmenopausal women.

Authors:  Fei Wang; Yi Cao; Fang Li; Jianlin Shan; Tianlin Wen
Journal:  Biomed Res Int       Date:  2014-12-15       Impact factor: 3.411

10.  OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men.

Authors:  Yizhou Li; Yuan Wang; Yongchang Guo; Quanjian Wang; Yongri Ouyang; Yuju Cao; Tianbo Jin; Jianzhong Wang
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.